[1]胥日,羊镇宇.冠状动脉非阻塞性心肌梗死的发病机制[J].心血管病学进展,2021,(2):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
 XU Ri,YANG Zhenyu.Pathogenesis and Imaging Manifestations of Myocardial Infarction with Non-obstructive Coronary Arteries[J].Advances in Cardiovascular Diseases,2021,(2):148.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.014]
点击复制

冠状动脉非阻塞性心肌梗死的发病机制()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年2期
页码:
148
栏目:
综述
出版日期:
2021-02-25

文章信息/Info

Title:
Pathogenesis and Imaging Manifestations of Myocardial Infarction with Non-obstructive Coronary Arteries
作者:
胥日羊镇宇
(南京医科大学附属无锡市人民医院心内科,江苏 无锡 214023)
Author(s):
XU RiYANG Zhenyu
(Department of Cardiology,Wuxi People’s Hospital Affiliated to Nanjing Medical University,Wuxi 214023,Jiangsu,China)
关键词:
心肌梗死非阻塞性冠状动脉疾病冠状动脉造影
Keywords:
Myocardial infarction Non-obstructive Coronary artery disease Coronary angiography
DOI:
10.16806/j.cnki.issn.1004-3934.2021.02.014
摘要:
(MINOCA)是指患者临床表现符合心肌梗死诊断标准,但行冠状动脉造影显示未见冠状动脉明显阻塞或狭窄50%。MINOCA在心肌梗死患者中发病率较,但往往因行造影时未发现有意义的血管狭窄易被忽视,造成预后不佳。本篇综述将概述已报道的MINOCA的发病机制其相关的影像学特征。
Abstract:
Myocardial infarction with non-obstructive coronary arteries(MINOCA) refers to patients whose clinical manifestations meet the diagnostic criteria for myocardial infarction,but whose coronary angiography shows no obvious coronary artery occlusion or stenosis<50%. MINOCA has a low incidence rate in patients with myocardial infarction,but it is often neglected due to the absence of meaningful vascular stenosis during coronary angiography,resulting in a poor prognosis.This review will summarize the reported pathogenesis and imaging features of MINOCA.

参考文献/References:

[1] T hygesen K,A lpert JS,J affe AS,et al. Fourth universal definition of myocardial infarction (2018)[J]. J Am Coll Cardiol,2018,72(18):2231-2264.

[2] Tamis-Holland JE , Jneid H , Reynolds HR , et al. Contemporary Diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease:a scientific statement from the American Heart Association [J].Circulation,2019,139(18):e891-e908.

[3] Raparelli V,Elharram M,Shimony A,et al. Myocardial infarction with no obstructive coronary artery disease:angiographic and clinical insights in patients with premature presentation[J]. Can J Cardiol,2018,34(4):468-476.

[4] Barr PR,Harrison W,Smyth D,et al. Myocardial infarction without obstructive coronary artery disease is not a benign condition (ANZACS-QI 10)[J]. Heart Lung Circ,2018,27(2):165-174.

[ 5 ] Agewall S,Beltrame JF,Reynolds HR,et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries[J]. Eur Heart,2017,38(3):143-153.

[ 6 ] Rigla J. Chapter 2Atherosclerotic plaque progression and OCT/IVUS assessment[J]. Computing and Visualization for Intravascular Imaging and Computer-Assisted Stenting,2017:33-51.

[7] White SJ, Newby AC, Johnson TW. Endothelial erosion of plaques as a substrate for coronary thrombosis[J]. Thromb Haemost,2016,115(3):509-519.

[ 8 ]Niccoli G , Scalone G , Crea F. Acute myocardial infarction with no obstructive coronary atherosclerosis:Mechanisms and management[J]. Eur Heart,2015,36(8):475-481.

[9] Cury RC,Abbara S,Achenbach S,et al. Coronary Artery DiseaseReporting and Data System (CAD-RADS):an expert consensus document of SCCT,ACR and NASCI:endorsed by the ACC[J]. JACC Cardiovasc Imaging,2016,9(9):1099-1113.

[10]Violi F,Soliman E.Z,Pignatelli P,et al. Atrial fibrillation and myocardial infarction:a systematic review and appraisal of pathophysiologic mechanisms[J]. J Am Heart Assoc,2016,5(5):e003347.

[11]Shibata T,Kawakami S,Noguchi T,et al. Prevalence,clinical features,and prognosis of acute myocardial infarction attributable to coronary artery embolism[J]. Circulation,2015,132(4):241-250.

[12]Chandrasekaran B,Kurbaan AS. Myocardial infarction with angiographically normal coronary arteries[J]. J R Soc Med,2020,95(8):398-400.

[13]Ouchi K,Ebihara T,Niitani M,et al. Diagnosis of infective endocarditis with cardiac CT in an adult[J]. Radiol Case Rep,2019,14(5):544-547.

[14]Souto ALM,Souto RM,Teixeira ICR,et al. Myocardial viability on cardiac magnetic resonance[J]. Arq Bras Cardiol,2017,108(5):458-469.

[15]Rajiah P,Desai MY,Kwon D,et al. MR imaging of myocardial infarction[J]. Radiographics,2013,33(5):1383-1412.

[16]Dastidar AG,Baritussio A,de Garate E,et al. Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries[J]. JACC Cardiovasc Imaging,2019,12(10):1973-1982.

[17]Romero J,Husain SA,Kelesidis I,et al. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation:a meta-analysis[J]. Circ Cardiovasc Imaging,2013,6(2):185-194.

[18]Pasupathy S,Air T,Dreyer RP,et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries[J]. Circ,2015,131(10):861-870.

[19]Sueda S,Kohno H. Spontaneous coronary artery spasm detected by computed tomography coronary angiography:provoked spasm site similar to intracoronary injection of ergonovine but not acetylcholine[J]. J Cardiol Cases,2019,20(6):209-212.

[20]Shimokawa H. 2014 Williams Harvey LECTURE:importance of coronary vasomotion abnormalities:from bench to bedside[J]. Eur Heart,2014,35(45):3180-3193.

[21]Nishimiya K,Matsumoto Y,Shindo T,et al. Association of adventitial vasa vasorum and inflammation with coronary hyperconstriction after drug-eluting stent implantation in pigs in vivo[J]. Circ J,2015,79(8):1787-1798.

[22]Ohyama K,Matsumoto Y,Nishimiya K,et al. Increased coronary perivascular adipose tissue volume in patients with vasospastic angina[J]. Circ,2016,80(7):1653-1656.

[23] Beltrame JF,Crea F,Kaski JC,et al. International standardization of diagnostic criteria for vasospastic angina.[J]. Eur Heart,2017,38(3):2565-2568.

[24]Ito T,Terashima M,Kaneda H,et al. In vivo assessment of ergonovine-induced coronary artery spasm by 64-slice multislice computed tomography[J]. Circ Cardiovasc Imaging,2012,5(2):226-2 32.

[25]Ong P,Camici PG,Beltrame JF,et al. International standardization of diagnostic criteria for microvascular angina[J]. Int J Cardiol,2018,250:16-20.

[26]Olin JW. Expanding clinical phenotype of fibromuscular dysplasia[J]. Hypertension,2017,70(3):488-489.

[27]Tweet MS,Hayes SN,Codsi E,et al. Spontaneous coronary artery dissection associated with pregnancy[J]. J Am Coll Cardiol,2017,70(4):426-435.

[28]Macaya F,Salinas P,Gonzalo N,et al. Spontaneous coronary artery dissection: contemporary aspects of diagnosis and patient management[J]. Open Heart,2018,5(2):e000884.

[29]Roura G,Ariza-Solé A,Rodriguez-Caballero IF,et al. Noninvasive follow-up of patients with spontaneous coronary artery dissection with CT angiography[J]. JACC Cardiovasc Imaging,2016,9(7):896-897.

[30]Migliore F,Maffei E,Marra MP,et al. LAD Coronary Artery Myocardial Bridging and Apical Ballooning Syndrome[J]. JACC Cardiovasc Imaging,2013,6(1):32-41.

[31]Forsdahl SH,Rogers IS,Schnittger I,et al. Myocardial bridges on coronary computed tomography angiographyCorrelation with intravascular ultrasound and fractional flow reserve[J]. Circ J,2017,81(12):1894-1900.

[32]Januzzi JL,Sandoval Y. The many faces of type 2 myocardial infarction[J]. J Am Coll Cardiol,2017,70(13):1569-1572.

相似文献/References:

[1]王铁华,郑景辉,莫云秋.蛋白质组学在心肌梗死中的研究进展[J].心血管病学进展,2015,(5):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
 WANG Tiehua,ZHENG Jinghui,MO Yunqiu.Research Progress of Proteomics in Myocardial Infarction[J].Advances in Cardiovascular Diseases,2015,(2):616.[doi:10.3969/j.issn.1004-3934.2015.05.024]
[2]孙洋.基质金属蛋白酶与心肌梗死后心脏重构[J].心血管病学进展,2019,(8):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
 SUN Yang.Matrix Metalloproteinases in Cardiac Remodeling after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(2):1094.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.006]
[3]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
 CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(2):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[4]常文婧 王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J].心血管病学进展,2019,(8):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
 CHANG Wenjin,WANG Lina.Role of Hippo Pathway in Heart Development,Regeneration and Disease[J].Advances in Cardiovascular Diseases,2019,(2):1115.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.011]
[5]王宇 周思维 张莎 吴弘.植入型心律转复除颤器在心肌梗死后心脏性猝死中的研究进展[J].心血管病学进展,2020,(1):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
 WANG Yu,ZHOU Siwei,ZHANG Sha,et al.Implantable Cardioverter Defibrillator in Sudden Cardiac Death after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(2):4.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.002]
[6]邹先明 赵然尊.长链非编码RNA ANRIL与心血管疾病的研究进展[J].心血管病学进展,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
 ZOU Xianming,ZHAO Ranzun.Long Non-Coding RNA ANRIL and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[7]王茜 李晶洁.细胞学机制在调控心肌梗死后炎症反应中的研究进展[J].心血管病学进展,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
 WANG QianLI Jingjie.Cytological Mechanisms in Regulation of The Post-infarction Inflammatory Response[J].Advances in Cardiovascular Diseases,2020,(2):190.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.023]
[8]黄柳,张瑞宁,田小超,等.内皮祖细胞与冠心病患者CD14CD16+单核细胞共培养后移植心肌梗死大鼠对血管密度及心肌梗死面积的影响[J].心血管病学进展,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
 HUANG Liu,ZHANG Ruining,TIAN Xiaochao,et al.Effects of Co-cultured Endothelial Progenitor Cells and CD14++CD16+ Monocytes from Coronary Heart Disease Patients on Vascular Density and Myocardial Infarction Size in Transplanting Myocardial Infarction Rats[J].Advances in Cardiovascular Diseases,2020,(2):203.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.027]
[9]刘玉婷,贾锋鹏.骨膜蛋白与心血管疾病的研究进展[J].心血管病学进展,2020,(3):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
 LIU Yuting,JIA Fengpeng.Roles of Periostin in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(2):239.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.006]
[10]谢建华,赵鸿泽,刘剑雄.MicroRNA在心肌梗死后左室重塑和心力衰竭发展中的研究现状[J].心血管病学进展,2020,(3):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
 XIE Jianhua,ZHAO Hongze,LIU Jianxiong.MicroRNA in Development of Left Ventricular Remodeling and Heart Failure after Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(2):259.[doi:10.16806 /j.cnki.issn.1004-3934.2020.03.011]
[11]牟肖霖 宋扬.冠状动脉非阻塞性心肌梗死:影像检查手段和诊断路径的新进展[J].心血管病学进展,2023,(9):805.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.009]
 MU Xiaolin,SONG Yang.Myocardial Infarction with NonObstructive Coronary Artery Disease:New Research Progress in Imaging Techniques and Diagnostic Pathway[J].Advances in Cardiovascular Diseases,2023,(2):805.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.009]

更新日期/Last Update: 2021-06-15